FGFR4 and pituitary tumor: Furthermore, Abbass along with colleagues, reported that FGFR4 undergoes NH2-terminal truncation, resulting in a pituitary tumor-derived FGFR4 variant (ptd-FGFR4) [9], initiated through alternative transcription initiation from a cryptic intronic promoter [10,11].